US 2003/0148996 A1Published application

Camptothecin complexes

OwnerJoseph Rubinfeld, Simeon M. Wrenn JR.inventors

Life of this patent

Estimating the term…

Abstract

Disclosed are compositions that include a camptothecin and an amorphous cyclodextrin. The camptothecin may be substituted or unsubstituted. Also disclosed are methods of treating undesirable or uncontrolled cell proliferation by administering the inventive compositions. Finally, implants including an implant structure and the inventive composition are disclosed.

Claims42

Dependent claims

A composition comprising a camptothecin and an amorphous cyclodextrin.

Dependencies are inferred from the claim text.

Facts

Application: 10/319,783Filed 13 Dec 2002
Priority: 31 Mar 2000
Published: 7 Aug 2003
Term ends: Not estimatedThe source records don’t support an estimate.

Classification17 codes

A61K 47/6957
The conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit: the form being a…
A61K 9/0019
Galenical forms characterised by the site of application: injectable compositions; Intramuscular, intravenous, arterial, subcutaneous…
A61K 31/4745
Ortho- or peri-condensed with heterocyclic ring systems: condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
A61K 31/724
Glucans: cyclodextrins

Family

Application09/539,982Continuation · filed 31 Mar 2000
Application10/319,783Continuation · filed 13 Dec 2002
US 2003/0148996 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results